CD44 Antibody (MEM-263) [FITC]

CD44 is a transmembrane glycoprotein expressed on the surface of most cells, which serves as a receptor for hyaluronan. CD44 mediates angiogenesis, cell adhesion, proliferation and migration, it is thus important for lymphocyte activation, recirculation and homing, it can thus serve e.g. as a modulator of macrophage recruitment in response to pathogen. Although CD44 functions are essential for physiological activities of normal cells, elevated CD44 expression correlates with poor prognosis in many carcinomas, facilitating tumour growth and metastasis, antiapoptosis and directional motility of cancer cells.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 1 confirmed species: Porcine.

We have publications tested in 1 application: FLOW.

Showing Publications 1 - 2 of 2.

Publications using NBP1-42789	Applications	Species
Leukocyte Typing III, McMichael AJ et al (Eds). Oxford University Press (1987).
Huang CC, Tsai HW, Lee WY et al. A translational approach in using cell sheet fragments of autologous bone marrow-derived mesenchymal stem cells for cellular cardiomyoplasty in a porcine model Biomaterials [PMID: 23528228] (FLOW, Porcine) Details: Used the FITC form of this antibody.	FLOW	Porcine

Array NBP1-42789

• CD44 Antibodies
• CD44 Antibody Pair
• CD44 ELISA Kits
• CD44 Lysates
• CD44 Protein
• CD44 ELISA
• CD44 Proteins and Enzymes